Wingene Farma SRL
Wingene Farma reported total assets of 246,428 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026).
The score of Wingene Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets +11 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wingene Farma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 33,839 € | ||||
| Equity | 181,628 € | ||||
| Cash | 41,895 € | ||||
| EBITDA | 56,734 € | ||||
| Total assets | 246,428 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Wingene Farma's financial analysis
- Solvency73.7%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wingene Farma
Wingene Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0668.455.803
- VAT number
- BE0668455803
- Peppol
- Registered · 0208:0668455803 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Dec 2016
- Registered office
- 8700 Tielt
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Leasing of intellectual property and similar products, except copyrighted works (NACE 77400)
Wingene Farma (SRL) has been based in Tielt since 2016, active in: leasing of intellectual property and similar products, except copyrighted works. For 2025, it reports a net profit of 33,839 € and equity of 181,628 €; its revenue is not published. Its solvency stands at 73.7%, above the median of its sector (58.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Wingene Farma
Companies in the same business, of comparable size and area, outside its group.
- Tielt Farma Leasing of intellectual property and similar products, except copyrighted works Tielt · balance sheet 201,947 €
- Endo-Precision Leasing of intellectual property and similar products, except copyrighted works Oostkamp · balance sheet 612,373 €
- Molipoly Leasing of intellectual property and similar products, except copyrighted works Herent · balance sheet 469,424 €
- Axis Investments Leasing of intellectual property and similar products, except copyrighted works Antwerp · balance sheet 157,033 €
- Strybol Sint-Gillis Leasing of intellectual property and similar products, except copyrighted works Bruges · balance sheet 163,919 €
- Apotheek Gopharma Leasing of intellectual property and similar products, except copyrighted works Nazareth-De Pinte · balance sheet 156,838 €
- Amudes Leasing of intellectual property and similar products, except copyrighted works Rotselaar · balance sheet 326,087 €
- Charleo Leasing of intellectual property and similar products, except copyrighted works Chaumont-Gistoux · balance sheet 59 €
Frequently asked questions about Wingene Farma
What is the revenue of Wingene Farma?
Wingene Farma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wingene Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0668455803 for Wingene Farma, if the company is VAT-registered. Its company number (CBE) is 0668.455.803.
Where is the registered office of Wingene Farma?
According to the CBE register, the registered office of Wingene Farma is in 8700 Tielt.
What is the equity of Wingene Farma?
At the close of the 2025 financial year, the equity of Wingene Farma amounts to 181,628 €, a solvency of 73.7% of total assets.
Who manages Wingene Farma?
The register lists 2 active mandates at Wingene Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wingene Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →